INTRODUCTION: Neuropathological studies suggest neuropil reduction in schizophrenia. Altered synaptic pruning is proposed to underlie neuropil reduction. Underlying factors and clinical correlates of synaptic pruning are poorly understood. Using phosphorus magnetic resonance spectroscopy (31P MRS), it is feasible to assess membrane phospholipid (MPL) metabolites in the brain that specifically and sensitively reflect neuropil expansion (elevated MPL precursors) or contraction (elevated MPL catabolites). METHODS: We examined MPL metabolites and their cognitive, clinical and immunologic correlates among 28 early-course schizophrenia individuals (illness duration 1.99±1.33 years; antipsychotic-naïve=18) and 21 controls. We acquired whole-brain multi-voxel 31P MRS data from 12 unique brain regions. Interleukin-6 and C-reactive protein (CRP) were assayed in the serum. Generalized linear mixed models examined case-control differences in MPL metabolites in these regions correcting for multiple testing. Partial correlations accounting for multiple tests examined the relationship of Interleukin-6 and CRP levels with MPL metabolite levels. RESULTS: MPL catabolite levels were increased in the thalamus in schizophrenia compared to controls. Interleukin-6 and CRP levels did not show case-control differences. Interleukin-6 levels positively correlated with MPL catabolite levels in the thalamus after correcting for multiple tests. The left thalamus MPL catabolite levels correlated negatively with sustained attention (corrected p=0.039). DISCUSSION: Elevated MPL catabolites in the thalamus suggest increased neuropil contraction that may be related to excessive synaptic pruning. The thalamic neuropil contraction is associated with Interleukin-6 levels suggesting central pathogenic mechanisms for the inflammatory mediators. Correlation of increased thalamic MPL catabolite levels with cognitive impairments suggests clinical correlates of neuropil contraction.
INTRODUCTION: Neuropathological studies suggest neuropil reduction in schizophrenia. Altered synaptic pruning is proposed to underlie neuropil reduction. Underlying factors and clinical correlates of synaptic pruning are poorly understood. Using phosphorus magnetic resonance spectroscopy (31PMRS), it is feasible to assess membrane phospholipid (MPL) metabolites in the brain that specifically and sensitively reflect neuropil expansion (elevated MPL precursors) or contraction (elevated MPLcatabolites). METHODS: We examined MPL metabolites and their cognitive, clinical and immunologic correlates among 28 early-course schizophrenia individuals (illness duration 1.99±1.33 years; antipsychotic-naïve=18) and 21 controls. We acquired whole-brain multi-voxel 31PMRS data from 12 unique brain regions. Interleukin-6 and C-reactive protein (CRP) were assayed in the serum. Generalized linear mixed models examined case-control differences in MPL metabolites in these regions correcting for multiple testing. Partial correlations accounting for multiple tests examined the relationship of Interleukin-6 and CRP levels with MPL metabolite levels. RESULTS:MPLcatabolite levels were increased in the thalamus in schizophrenia compared to controls. Interleukin-6 and CRP levels did not show case-control differences. Interleukin-6 levels positively correlated with MPLcatabolite levels in the thalamus after correcting for multiple tests. The left thalamus MPLcatabolite levels correlated negatively with sustained attention (corrected p=0.039). DISCUSSION: Elevated MPLcatabolites in the thalamus suggest increased neuropil contraction that may be related to excessive synaptic pruning. The thalamic neuropil contraction is associated with Interleukin-6 levels suggesting central pathogenic mechanisms for the inflammatory mediators. Correlation of increased thalamic MPLcatabolite levels with cognitive impairments suggests clinical correlates of neuropil contraction.
Entities:
Keywords:
Cognitive performance; Cytokines; Inflammation; Magnetic Resonance Spectroscopy; Neuropil; Schizophrenia
Authors: Konasale M Prasad; Catherine H Upton; Vishwajit L Nimgaonkar; Matcheri S Keshavan Journal: Schizophr Res Date: 2014-10-22 Impact factor: 4.939
Authors: Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman Journal: Nature Date: 2009-07-01 Impact factor: 49.962
Authors: H P Volz; R Rzanny; G Rössger; G Hübner; I Kreitschmann-Andermahr; W A Kaiser; H Sauer Journal: Biol Psychiatry Date: 1998-09-15 Impact factor: 13.382
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: T G M van Erp; D P Hibar; J M Rasmussen; D C Glahn; G D Pearlson; O A Andreassen; I Agartz; L T Westlye; U K Haukvik; A M Dale; I Melle; C B Hartberg; O Gruber; B Kraemer; D Zilles; G Donohoe; S Kelly; C McDonald; D W Morris; D M Cannon; A Corvin; M W J Machielsen; L Koenders; L de Haan; D J Veltman; T D Satterthwaite; D H Wolf; R C Gur; R E Gur; S G Potkin; D H Mathalon; B A Mueller; A Preda; F Macciardi; S Ehrlich; E Walton; J Hass; V D Calhoun; H J Bockholt; S R Sponheim; J M Shoemaker; N E M van Haren; H E H Pol; R A Ophoff; R S Kahn; R Roiz-Santiañez; B Crespo-Facorro; L Wang; K I Alpert; E G Jönsson; R Dimitrova; C Bois; H C Whalley; A M McIntosh; S M Lawrie; R Hashimoto; P M Thompson; J A Turner Journal: Mol Psychiatry Date: 2015-08-18 Impact factor: 15.992
Authors: Cagri Yuksel; Xi Chen; Virginie-Anne Chouinard; Lisa D Nickerson; Margaret Gardner; Talia Cohen; Dost Öngür; Fei Du Journal: Schizophr Bull Open Date: 2021-01-30
Authors: Tulsi A Malavia; Srilakshmi Chaparala; Joel Wood; Kodavali Chowdari; Konasale M Prasad; Lora McClain; Anil G Jegga; Madhavi K Ganapathiraju; Vishwajit L Nimgaonkar Journal: NPJ Schizophr Date: 2017-02-24
Authors: Maja Kopczynska; Wioleta Zelek; Samuel Touchard; Fiona Gaughran; Marta Di Forti; Valeria Mondelli; Robin Murray; Michael C O'Donovan; B Paul Morgan Journal: Schizophr Res Date: 2017-12-24 Impact factor: 4.939